GSK plc
GSK is seeking a Process Discovery Chemist to join its oligonucleotide synthesis lab, bridging early discovery-stage chemistry with process rigor to reliably deliver in vivo study material. The role involves developing and troubleshooting solid-phase oligonucleotide synthesis routes at milligram-to-gram scale, optimizing chromatography and purification strategies, and ensuring these methods translate cleanly to larger-scale production. This position requires expertise in oligonucleotide therapeutics, including ASOs, siRNA, and RNA editors, to generate high-quality, reproducible material for rodent and NHP studies.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
38% above the average for this role
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
PhD‑Level Scientist – Oligonucleotide Synthesis Lead
Novartis
Senior Scientist – Small Scale Oligonucleotide Synthesis (80-100%*)
Diversity Employment
PhD‑Level Scientist – Oligonucleotide Synthesis Lead
Novartis
Scientist/Sr Scientist - Oligonucleotide Chemistry
Eli Lilly and Company
Research Scientist I/II, Oligonucleotide Chemistry
Diversity Employment
Senior Scientist, siRNA Synthesis
AbbVie